“Diversity: the art of thinking independently together”

– Malcolm Stevenson Forbes

By delivering breakthrough therapies that can harness the immune system, we aim to conquer cancer and save lives

The Amunix site focuses on immuno-oncology, leveraging our proprietary, clinically validated PRO-XTEN™ technology platform to discover and develop transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer. We aim to expand the therapeutic index of TCEs and cytokines, which have demonstrated anti-tumor clinical activity, but have not realized their potential due to dose-limiting on-target, off-tumor toxicity.

We address this challenge by using our universal, protease-releasable masking technology (PRO-XTEN), to create next generation, conditionally active TCEs (XPAT® proteins) and cytokines (XPAC™ proteins), that are preferentially activated in tumors as compared to healthy tissues.

Experience and culture matter. At the Amunix site, we challenge ourselves and our colleagues, and bring a critical eye and rigor to everything we do. Biology is complex and hard to predict, but with deep experience, diversity of thinking, and scientific rigor, we believe we maximize our chance of making a real difference for cancer patients.

Sanofi Governance page: https://www.sanofi.com/en/about-us/governance


Leadership Team

Mika Derynck photo

Mika Kakefuda Derynck, M.D.

Chief Medical Officer

Maninder Hora photo

Maninder Hora, Ph.D.

Chief Technical Operations Officer

Grace Jiang photo

Grace Jiang, Ph.D.

Head of Regulatory


Volker Schellenberger photo

Volker Schellenberger, Ph.D.

Chief Technology Officer

Geetha Shankar photo

Geetha Shankar, Ph.D.

Head Of Clinical Development Oncology and Head of the Amunix site

Gary Taniguchi photo

Gary T. Taniguchi, Ph.D.


Code of Ethics

Compliance Helpline

Allows confidential, anonymous reporting of concerns that may violate our Company Code of Ethics, policies or law and is available to NA personnel 24/7.

Visit https://sanofi.ethicspoint.com or call 1-800-648-1297.